Class IITerminated

Fosaprepitant for Injection 150 mg per vial recall

FDA recall D-0262-2024 · initiated Jan 10, 2024

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Lack of Sterility Assurance: Aseptic process simulation failure.

Details

Product: Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.
Recalling company: Be Pharms
Classification: Class II
Status: Terminated
Type: Voluntary: Firm initiated
Distribution: Nationwide in the USA
Initiated: Jan 10, 2024
FDA report date: Jan 31, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0262-2024 ↗

← All drug recalls